# Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

> **NCT04329221** · PHASE2 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Cutaneous Squamous Cell Carcinoma
- Actinic Keratoses
- Skin Cancer
- Organ Transplant Recipients
- Immunotherapy

## Interventions

- **DRUG:** Calcipotriol Only Product in Cutaneous Dose Form
- **DRUG:** Vaseline
- **DRUG:** Topical 5FU

## Key facts

- **NCT ID:** NCT04329221
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01-01
- **Primary completion:** 2029-01
- **Final completion:** 2030-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn due to lack of financial support.
- **Last updated:** 2025-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04329221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04329221, "Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04329221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*